We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$663M
AUM Growth
-$835M
Cap. Flow
-$859M
Cap. Flow %
-129.52%
Top 10 Hldgs %
36.6%
Holding
684
New
251
Increased
107
Reduced
109
Closed
206

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$123M
2
BABA icon
Alibaba
BABA
+$16.4M
3
AMD icon
Advanced Micro Devices
AMD
+$12.3M
4
MELI icon
Mercado Libre
MELI
+$12.3M
5
CDNS icon
Cadence Design Systems
CDNS
+$10.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$541M
2
IBB icon
iShares Biotechnology ETF
IBB
+$152M
3
PFE icon
Pfizer
PFE
+$147M
4
LLY icon
Eli Lilly
LLY
+$77.2M
5
GILD icon
Gilead Sciences
GILD
+$66M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Technology 17.81%
3 Consumer Discretionary 13.64%
4 Healthcare 9.49%
5 Financials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LW icon
576
Lamb Weston
LW
$7.12B
– –
-2,616
Closed -$234K
LXRX icon
577
Lexicon Pharmaceuticals
LXRX
$1.07B
– –
-46,281
Closed -$88.4K
LZB icon
578
La-Z-Boy
LZB
$1.66B
– –
-13,651
Closed -$312K
MCK icon
579
McKesson
MCK
$103B
– –
-3,416
Closed -$1.28M
MDT icon
580
Medtronic
MDT
$114B
– –
-40,774
Closed -$3.17M
MKSI icon
581
MKS Inc
MKSI
$19.8B
– –
-2,537
Closed -$215K
MLR icon
582
Miller Industries
MLR
$606M
– –
-33,755
Closed -$900K
MRNA icon
583
CALL
Moderna
MRNA
$23.9B
– –
-10,000
Closed -$1.8M
MSFT icon
584
Microsoft
MSFT
$3.76T
– –
-27,500
Closed -$6.6M
MSFT icon
585
PUT
Microsoft
MSFT
$3.76T
– –
-27,500
Closed -$6.6M
MSM icon
586
MSC Industrial Direct
MSM
$6.87B
– –
-5,876
Closed -$480K
MU icon
587
Micron Technology
MU
$972B
– –
-43,147
Closed -$2.16M
NAT icon
588
CALL
Nordic American Tanker
NAT
$1.33B
– –
-50,000
Closed -$153K
NAT icon
589
Nordic American Tanker
NAT
$1.33B
– –
-108,149
Closed -$331K
NBIX icon
590
Neurocrine Biosciences
NBIX
$16.8B
– –
-4,869
Closed -$582K
NBR icon
591
Nabors Industries
NBR
$1.33B
– –
-1,931
Closed -$299K
NKTR icon
592
Nektar Therapeutics
NKTR
$2.53B
– –
-17,312
Closed -$587K
NMFC icon
593
New Mountain Finance
NMFC
$726M
– –
-48,360
Closed -$598K
NTES icon
594
NetEase
NTES
$85.4B
– –
-9,474
Closed -$688K
NVGS icon
595
Navigator Holdings
NVGS
$1.25B
– –
-12,840
Closed -$154K
O icon
596
Realty Income
O
$58.6B
– –
-4,968
Closed -$315K
OCSL icon
597
Oaktree Specialty Lending
OCSL
$1.12B
– –
-20,173
Closed -$416K
OLED icon
598
Universal Display
OLED
$4.16B
– –
-2,169
Closed -$234K
ON icon
599
ON Semiconductor
ON
$31.1B
– –
-25,000
Closed -$1.56M
PAGS icon
600
PagSeguro Digital
PAGS
$2.54B
– –
-26,745
Closed -$234K
22 23
24
25 26

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Caxton Associates (New York) held 684 positions worth $663M, down 56% from $1.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Caxton Associates (New York) withdrew a net $859M in Q1 2023, closing 206 positions and reducing 109 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 0.33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Advanced Micro Devices worth $14.8M.

  • Caxton Associates (New York)'s largest Q1 2023 buy was Advanced Micro Devices: 151,421 shares worth $14.8M.
  • Caxton Associates (New York) added most to Freeport-McMoran in Q1 2023, an estimated $123M increase.
  • Caxton Associates (New York)'s biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $541M.
  • Caxton Associates (New York) fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $152M.
  • Caxton Associates (New York)'s ten largest holdings make up 37% of its $663M portfolio in Q1 2023.
  • Caxton Associates (New York) opened 251 new positions and closed 206 in Q1 2023.
  • Caxton Associates (New York)'s portfolio value fell 56% quarter-over-quarter to $663M.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.